ARTICLE
6 March 2023

False Claims Act Statistical Year In Review — A Study In Contrasts

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
A year-end review of False Claims Act (FCA) case activity in 2022 reveals substantial growth in overall FCA enforcement activity, coupled with a decline in health care-related cases.
United States Food, Drugs, Healthcare, Life Sciences

In this edition of EnforceMintz, we analyze trends in False Claims Act (FCA) investigations and lawsuits using data compiled by Mintz in its Qui Tam Database, the annual report of FCA statistics published by the Department of Justice (DOJ), and DOJ's discussion of FCA enforcement trends and recoveries that accompanied its annual report.

While the $2.2 billion in FCA recoveries in fiscal year (FY) 2022 fell below the prior year's amount of $5.6 billion, DOJ emphasized that it had obtained the second-highest number of FCA settlements in history in FY 2022. Health care FCA cases continued to generate the vast majority of FCA recoveries, accounting for $1.7 billion of the total FY 2022 recoveries. Qui tam FCA cases filed by relators exceeded 650 cases, and DOJ emphasized the continued significance of relators to drive FCA recoveries: over $1.9 billion out of $2.2 billion recovered in FY 2022 resulted from qui tam cases.

We also utilize the FCA statistics to provide insights on the trends and government priorities driving FCA cases and offer our predictions on the future of health care FCA cases. Click here to view the statistics and our analysis.

For additional health care enforcement analysis, view our recently released Health Care Enforcement Year In Review & 2023 Outlook, which reports on qui tam FCA cases, other government enforcement actions, and significant regulatory developments from the past year.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More